In the focal infarction model of the rat middle cerebral artery (MCA), the thalamus of the occluded side becomes gradually atrophic, mainly because of retro grade degeneration. We determined whether basic fibro blast growth factor (bFGF) administered intracisternally could prevent this thalamic atrophy. We occluded the left MCA through a small cranial opening, and animals were then divided into two groups. One group received intra cisternal injections of recombinant bFGF (1 fLg dissolved in 0.1 ml of saline with 2% rat serum) starting I day after occlusion and repeated once a week to a total dose of 4 fLg by four injections. The other group received vehicle so lution by the same schedule. The animals were perfused and fixed at 28 days after occlusion, and histological ex amination was made at the level of the caudoputamen and thalamus. In the bFGF-treated rats, the area of the pos terior ventral thalamus of the occluded side was 93% of that of the contralateral side, i.e., significantly larger than in the normal saline-treated rats (75%, p < 0.01). The
In focal infarction of the middle cerebral artery (MeA) in rats, the thalamus of the infarcted side gradually becomes atrophic (Fujie et aI. , 1989; Kataoka et aI., 1989; Taguchi et aI., 1989) . The thal amus of the infarcted side has many deafferented nerve terminals (Kataoka et aI., 1989) , because the corresponding cell bodies come from the primary somatosensory cortex and have died by infarction. Furthermore, many thalamic neurons are de-infarction size was not statistically different in the two groups. Microscopic observation indicated that normal saline-treated animals showed shrinkage and disappear ance of thalamic neurons, whereas bFGF-treated groups showed preservation of thalamic neurons. Computerized analysis of the cell size substantiated this observation. To assess the effect of bFGF on astrocytes, bFGF or vehicle solution was injected into normal rats, and their histology was evaluated at 1, 2, and 4 weeks after injection. The bFGF-injected group showed a significant increase in glial fibrillary acidic protein-positive astrocytes in the brain tissue facing the ventriculocisternal system. The re sults suggest that bFGF prevents retrograde degeneration of thalamic neurons by working directly as a neurotrophic factor of these neurons or by activating astrocytes located in the thalamocortical pathway. Key Words: Experimen tal ischemia-MCA occlusion-Basic FGF-Retrograde degeneration-Neurotrophic factor. efferented, because their axons and terminals are widely distributed to the cortex of the infarcted MeA territory. Our previous study suggested that thalamic atrophy following MeA occlusion was caused mainly by retrograde degeneration (Kataoka et aI., 1989; Taguchi et aI., 1989; Yamada et aI., 1989) .
It is well known that cholinergic neurons of the medial septum die following fimbria-fornix transec tion because of retrograde degeneration, and that exogenous administration of nerve growth factor (NGF) reverses this retrograde cell death of the sep tal cholinergic neurons (Hefti, 1986; Williams et aI. , 1986) . NGF, therefore, plays a key role as a neuro trophic factor of the cholinergic neurons. However, it only supports the survival of cholinergic neurons, but not that of thalamic neurons. If we consider degeneration of the thalamic neurons as due to a lack of neurotrophic factor, it might be prevented by proper administration of such a factor.
Recent reports indicate that basic fibroblast growth factor (bFGF) supports the survival of a rather wide range of central neurons in vitro (Mor rison et aI., 1986; Walicke, 1988) . We recently found that cultured thalamic neurons have been helped to survive by bFGF (Yamada et aI., unpub lished data) . Furthermore, bFGF infused continu ously into the lateral ventricle (Anderson et al. , 1988) or soaked in Gelfoam and placed in the sur gical wound (Otto et aI., 1989) prevented retrograde cell death of the septal neurons after transection of the fimbria-fornix in vivo. These data suggest that bFGF has a neurotrophic effect on a rather wide range of central neurons and may be a good candi date for prevention of retrograde thalamic degener ation after MCA occlusion. We therefore investi gated whether intracisternal injection of bFGF might prevent thalamic atrophy following infarction of the MCA territory.
MATERIALS AND METHODS

Recombinant human bFGF CS23
Recombinant human bFGF mutein CS23 was kindly provided by Takeda Chemical Industries Ltd. (Osaka, Ja pan). The cDNA encoding human bFGF was modified by site-directed mutagenesis and expressed in Escherichia coli under the control of the trp promoter (Iwane et aI. , 1987; Seno et aI. , 1988) . In bFGF CS23, two cysteine residues (Cys69 and Cys87) are re placed by serine residues to stabilize the molecules. The product was purified by heparin-affinity high-per formance liquid chromatography (HPLC), and its purity was assured by polyacrylamide gel electrophoresis. The biological activity was evaluated by mouse 3T3 cells in vitro and by angiogenesis on the chick embryo chorioal lantoic membrane (Seno et aI., 1988) .
Ischemia model and administration of bFGF
Techniques for occlusion of the MCA (Tamura et aI., 1981 (Tamura et aI., , 1986 have been employed in our laboratory (Kataoka et aI., 1989) , and were used in this experiment. Twenty female Wi star rats weighing approximately 250 g were anesthetized by intraperitoneal injection of ket amine hydrochloride (150 mg/kg). They were additionally anesthetized with topical application of 1 % lidocaine so lution to the surgical wounds. The left MCA was reached by a small opening of the skull and dura. The arachnoid around the artery was torn, and the middle cerebral artery was cauterized at the level of the olfactory tract. The rats were randomly divided into two groups, one for bFGF and the other for normal saline, by intracisternal injec tion.
The bFGF was dissolved in normal saline containing 0.2% of autologous rat serum as a carrier, with a final concentration of 10 f,Lg/ml. Mter MCA occlusion, 10 rats received 0.1 ml of bFGF solution (I f,Lg of bFGF) by per-cutaneous injection to the cisterna magna using a tech nique of cisternal puncture (Ushio et aI., 1977; Arita et aI. , 1988) . The other 10 rats received normal saline con taining 0.2% rat serum. Intracisternal injection of bFGF or normal saline was started 24 h after MCA occlusion and repeated every week for 3 weeks; thus, bFGF-treated animals received 4 f,Lg of bFGF as a total dose.
Histological evaluation
Four weeks after MCA occlusion, the animals were deeply anesthetized by pentobarbital (50 mg/kg intraper itoneally), killed by transcardiac perfusion of normal sa line with heparine (10 units/ml), and fixed with 4% paraformaldehyde in 0.1 M phosphate buffer (pH = 7.4). The brains were postfixed with 4% paraformaldehyde for 24 h at 4°C, dehydrated, and embedded in paraffin. To obtain symmetrical coronal planes, blocks were carefully cut in 6 f,Lm sections and used for histological evaluation at the level of the caudoputamen and thalamus [0.7 mm anteriorly and 3.3 mm posterior from the bregma, respec tively, according to the atlas of Paxinos and Watson (1982) ]. They were stained with Luxol-fast blue-cresyl violet or cresyl violet (Nissl) alone. Stained sections were magnified by a projector and the posterior ventral thala mus of both sides was traced on a paper. The cross sectional area of the posterior ventral thalamus was mea sured by a planimeter, and the occluded side was com pared to the contralateral side. The size of the infarction was assessed by measuring the cross-sectional area of each hemisphere at the level of the caudoputamen. The final data were expressed as percentages of the contra lateral side. The statistical difference between the bFGF treated group and the normal-saline-treated group was assessed by the nonparametric Mann-Whitney U test.
Degeneration of the thalamic neurons was evaluated microscopically by measuring the size of each cell by a computerized image processing system (Nexus 6400 Sys tem produced by Kashiwagi, Tokyo, Japan). The Nissl stained sections were magnified 400 times by a micro scope (Olympus, Tokyo, Japan) and connected to a video camera (Ikegami, Tokyo, Japan). The video image was transferred to an image processing system, and Nissl stained cells were converted to a green color. A square of 0.1 6 x 0. 16 mm (300 x 300 pixels) was set to the video image as a region of interest, and the size of each cell within the square was measured and expressed as a pixel size. Cell numbers and sizes were obtained from five re gions of interest, and their means were used as data. The final data were expressed as histograms each of 100 pixel size and the ordinate was expressed by the following for mula: cell number of lesion side/(cell number of lesion side + cell number of contralateral side) x 100 (%).
To detect reactive gliosis caused by infarction and ad ministration of bFGF, sections were immunostained for glial fibrillary acidic protein (GFAP). The anti-GFAP an tibody was obtained from Labsystem and diluted to 1:500. The reaction was visualized by the Vectastain ABC-Elite kit. GFAP-positive astrocytes were counted in the paraventricular white matter, subbasal cisternal tis sue, hippocampus, and thalamus. In these areas, GFAP positive cells were counted per 0.6 mm2 field. Five such fields were counted and the means were used as data. The final data were expressed as the number of GFAP positive cells per mm2• Statistical analysis between bFGF-treated animals and normal-saline-injected animals was made by the Mann-Whitney U test.
Effects of intracisternal bFGF on normal rats
The effects of intracisternally administered bFGF on astrocytes were evaluated by the following method: 20 Wistar rats weighing approximately 250 g were anesthe tized with ether, and bFGF (1 ILg/O.l ml) or normal saline with 0.2% rat serum was injected into the cisterna magna. They were perfused with normal saline, and the brains were fixed with 4% paraformaldehyde at 1, 2, and 4 weeks after administration (three rats each at 1 and 2 weeks and four rats at 4 weeks). They were embedded in paraffin, thin sliced, and immunostained for GFAP as de scribed above. The GFAP-positive astrocytes were counted by the same method as described above and ex pressed as the number of GF AP-positive astrocytes per mm2• Statistical analysis was made as indicated above.
RESULTS
Two of the bFGF-treated rats and two of the nor mal-saline-treated rats died of complications of an esthesia and intracisternal injection. Therefore, eight animals of each group were processed for tis sue preparation. Infarction size as estimated by the cross-sectional area of hemispheres at the caudate level was not statistically different between the bFGF-treated group and the normal-saline-treated group (Fig. I) . In the bFGF-treated rats, the cross sectional area of the posterior ventral thalamus of the occluded side was 93% of that of the contralat eral side, i.e., significantly larger than that of nor mal-saline-treated rats (75%; see Fig. 2 ). It thus ap pears that bFGF substantially prevented thalamic atrophy caused by cortical infarction.
Cresyl violet (Nissl) staining of the saline group showed shrinkage and disappearance of the tha lamic neurons. The bFGF-treated rats, however, showed preservation of the majority of thalamic neurons (Fig. 3 ). Both groups showed proliferation of small cells, which were proven to be astrocytes by GF AP immunostaining. Computerized analysis clearly indicated that bFGF preserved large cells, which were presumably neurons, in the thalamus on the side of the lesion. The bFGF-treated group had a greater number of cells with size of 400 to 600 pixels than that of control group (Fig. 4) .
To assess the effect of bFGF on astrocytes, GF AP-positive astrocytes were counted in animals with MCA occlusion that had been treated with bFGF or normal saline. In the area of paraventric ular white matter, subbasal cisternal tissue, and hip pocampal CAl (Fig. 5A) , the density of GFAP positive astrocytes was not statistically different be tween the lesion and contralateral sides. These data were therefore pooled and used as one value. In these areas, bFGF-treated animals tended to have a higher density of GF AP-positive astrocytes than normal-saline-treated animals, though this did not reach statistical significance in the paraventricular white matter and hippocampal CAL In the thala mus, however, the side of the lesion showed a much higher density of GF AP-positive astrocytes than the contralateral side, though the bFGF-treated and normal-saline-treated animals showed no statistical difference. The glial reaction in the thalamus might be caused by anterograde and retrograde degener ation (Fig. 5 ).
Since the astrocytic reaction caused by bFGF could be masked by infarction itself, in which reac tive astrocytes appear throughout the brain, we de termined the effects of bFGF on the normal rat brain. We counted GFAP-positive astrocytes in rats after intracisternal injection of bFGF or normal sa line. The density of GF AP-positive astrocytes at 1, 2, and 4 weeks after injection was not statistically different between the groups. The data were there fore pooled, and bFGF-treated rats and saline treated rats were compared. It appeared that bFGF significantly increased the number of GFAP positive astrocytes in the paraventricular white matter and subbasal cisternal tissue (p < 0.01). There was also a statistical difference (p < 0.05) between the two groups in the thalamus and hip pocampus (Fig. 6) . The difference was visualized substantially by immunostaining photographs (Fig. 7) .
DISCUSSION
As we pointed out in the previous communication (Kataoka et aI. , 1989) , the cell bodies of the tha lamic neurons became retrogradely damaged after ischemic axonal injury. This was clearly demon strated by succinate dehydrogenase histochemistry, in which the thalamus of the ischemic side showed reduced activity 4 days after the onset of ischemia. At this time, no definite histological changes were observed in the soma of the thalamic neurons by light microscopy (Taguchi et aI. , 1989) . N euroana- were selected for histological evaluation, and the density of GFAP-positive astrocytes in those areas was compared between saline-treated animals and bFGF-treated animals (8).
tomical study indicates that thalamic neurons have a dense projection to the somatosensory area of the cortex (Jacobson and Trojanowski, 1975) . When the somatosensory cortex was widely removed by sur gical ablation, thalamic neurons selectively shrank and died because of retrograde degeneration (Bar ron et al., 1973) . Under electron microscopic obser vation, thalamic neurons started to change within 2 days after ablation, showing deterioration of the en doplasmic reticulum with an apparent ribosomal loss (Matthews, 1973) . Under light microscopy, tha lamic neurons started to shrink within 3-4 days af ter cortical ablation (Cooper et al., 1984) . On the other hand, microscopic changes of thalamic neu rons were not evident within 1 week after ischemic infarction, probably as a result of slow progression of the effects . The present study, however, indicated the occurrence of late J Cereb Blood Flow Metab, Vol. II, No.3, 1991 thalamic atrophy, due to retrograde degeneration, within 1 month after MCA occlusion.
In the septohippocampal cholinergic neurons, transection of the fimbria-fornix caused retrograde degeneration, and intraventricular administration of NGF prevented it (Hefti, 1986; Williams et al., 1986) . It is commonly believed, therefore, that with proper administration of a neurotrophic factor, neu rons with their injured axons might be rescued with out retrograde degeneration.
We selected bFGF as a candidate for neuro trophic factor for thalamic neurons, because it sup ported the survival of cortical, hippocampal, and thalamic neurons in vitro. It also prevented the death of these neurons after hypoxic stress (Ya mada et al., unpublished observations) . The second reason why we selected bFGF is the generous sup ply of the stabilized mute in of recombinant human bFGF (Seno et al., 1988) . This recombinant form is stable and keeps equivalent biological activity to native bFGF, as tested by the angiogenetic activity of chick embryo chorioallantoic membrane. This mute in partially reversed retrograde death of septal neurons after fimbrial transection, when soaked in Gelfoam and applied to the transected area (Suno et al., personal communication) . We selected percuta neous intracisternal administration as the route of drug delivery, because this technique has been per formed in our laboratory and wide distribution of drugs to the ventriculocisternal system is well doc umented (Arita et al., 1988) .
As expected, intracisternal administration of bFGF prevented retrograde degeneration of the tha lamic neurons after MCA occlusion. This is clearly demonstrated by macroscopic measurement of tha lamic atrophy and by microscopic evaluation and computerized measurement of the cell size of tha- lamic neurons. The mechanism of prevention of ret rograde degeneration must now be discussed. The first possibility is the effect of bFGF as a neuro trophic factor. As described above, bFGF sup ported the survival of cultured thalamic neurons and reversed hypoxic neuronal injury in vitro. Therefore, bFGF can be a neurotrophic factor for thalamic neurons when their axons are injured by ischemia. The normal Wistar rats that received an intracisternal injection of bFGF showed a wide range of GF AP-positive astrocytes in the tissue fac ing the ventriculocisternal system. The distribution of this astrocytic response was identical to that of a radiotracer-Iabeled drug injected into the cisterna magna (Arita et aI., 1988) . It is therefore reasonable to consider that bFGF diffused to the part of the brain facing the ventriculocisternal system and ac tivated astrocytes to produce GFAP to a level de tectable by immunohistochemistry. The area of as trocytic reaction, which must be similar to the dis tribution of bFGF, correlated with the pathways of thalamocortical fibers. The data suggest that intra cisternal bFGF has a direct supportive effect on the injured thalamic neurons and prevents retrograde degeneration. The second possibility is an indirect effect of bFGF on neurons through reactive astrocytes. The bFGF has a rather wide range of target cells. In the cortical ablation model, bFGF immunoreactivity was detected in the glial cells at the ablation edge, and such an increase in local bFGF concentration might be beneficial for glial and capillary prolifera tion, and for neuronal sprouting (Finklestein et aI., 1988) . In the present infarction model, bFGF activated astrocytes may have a supportive effect on the neurons suffering from ischemic axonal in jury. It is well known that astrocytes secrete NGF (Furukawa et aI., 1987) , and reactive gliosis might produce NGF for collateral sprouting of cholinergic neurons (Gage et al. , 1988) . The supportive effect of astrocytes on the injured thalamic neurons may therefore be due both to secretion of some factor and to mechanical contact with the neurons. Al though further study is needed for analysis of the mechanism, the results obtained in this study may have important implications for the use of bFGF in the treatment of slowly progressing ischemic injury.
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